Chun Ma

An overview on therapeutics attenuating amyloid β level in Alzheimer's disease: targeting neurotransmission, inflammation, oxidative stress and enhanced cholesterol levels.

Xiaoling Zhou, Yifei Li, Xiaozhe Shi, 2016, American journal of translational research.

Preparation of baicalin-loaded ligand-modified nanoparticles for nose-to-brain delivery for neuroprotection in cerebral ischemia

Chun Ma, Xinxin Li, Shuling Li, 2022, Drug delivery.

Pharmacological mechanism and therapeutic efficacy of Icariside II in the treatment of acute ischemic stroke: a systematic review and network pharmacological analysis

Chun Ma, Jinhua Li, Xu Wang, 2022, BMC Complementary Medicine and Therapies.

RVG29-modified microRNA-loaded nanoparticles improve ischemic brain injury by nasal delivery

Chun Ma, Bixi Sun, Rubin Hao, 2020, Drug delivery.

Pharmacology, Toxicology, and Rational Application of Cinnabar, Realgar, and Their Formulations

Yan Xu, Chun Ma, Dexi Zhao, 2022, Evidence-based complementary and alternative medicine : eCAM.

Role of Atractylenolide I in Cerebral Ischemia Reperfusion Injury

Chun Ma, Dexi Zhao, P. Niu, 2023, Revista Brasileira de Farmacognosia.

Clarifying the mechanism of apigenin against blood–brain barrier disruption in ischemic stroke using systems pharmacology

Chun Ma, Dexi Zhao, Junchao Yu, 2023, Molecular diversity.

Bioinformatics analysis indicates that microRNA‑628‑5p overexpression may alleviate Alzheimer's disease by targeting TYROBP.

Haining Lin, Xinna Wang, Chun Ma, 2020, Molecular medicine reports.